A 5-year-old male with Gaucher's disease type 3 developed progressive mesenteric and mediastinal lymphadenopathy over 12 months, despite enzyme replacement therapy, contributing to the development of a protein-losing enteropathy. These complications are unique, indicating poorly accessible, differentially responsive compartments in patients with Gaucher's disease who are receiving enzyme therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2006.10.062DOI Listing

Publication Analysis

Top Keywords

progressive mesenteric
8
mesenteric mediastinal
8
mediastinal lymphadenopathy
8
despite enzyme
8
enzyme therapy
8
gaucher's disease
8
gaucher disease
4
disease progressive
4
lymphadenopathy despite
4
therapy 5-year-old
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!